Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials

Published:2018-02-01 Issue:4 Volume:26 Page:1029-1038
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Menshawy Amr,Mattar Omar,Abdulkarim Ali,Kasem Shiref,Nasreldin Noha,Menshawy Esraa,Mohammed Salahuddean,Abdel-Maboud Mohamed,Gadelkarim Mohamed,El Ashal Gehad Gamal,Elgebaly Ahmed Saber^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-018-4060-1/fulltext.html

Reference35 articles.

1. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res An Off J Am Assoc Cancer Res 12(20):6243s–6249s. https://doi.org/10.1158/1078-0432.CCR-06-0931

2. Costa L, Badia X, Chow E et al (2008) Impact of skeletal complications on patients’ quality of life, mobility, and functional independence. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 16(8):879–889. https://doi.org/10.1007/s00520-008-0418-0

3. Pockett RD, Castellano D, McEwan P et al (2010) The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. Eur J Cancer Care (Engl) 19(6):755–760. https://doi.org/10.1111/j.1365-2354.2009.01135.x

4. Hofbauer LC, Neubauer A, Heufelder AE (2001) Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases. Cancer 92:460–470

5. Ruza I, Mirfakhraee S, Orwoll E, Gruntmanis U (2013) Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions. Ther Adv Musculoskelet Dis 5(4):182–198. https://doi.org/10.1177/1759720X13485829

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone targeted nano-drug and nano-delivery;Bone Research;2024-09-04

2. 6-O-angeloylplenolin inhibits osteoclastogenesis in vitro via suppressing c-Src/NF-κB/NFATc1 pathways and ameliorates bone resorption in collagen-induced arthritis mouse model;Biochemical Pharmacology;2024-06

3. Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone Metastases;American Journal of Clinical Oncology;2024-01-11

4. Predictors of mortality in lung cancer patients hospitalized with community-acquired pneumonia;Annals of Clinical and Analytical Medicine;2024

5. Hypercalcemia of Malignancy;Textbook of Palliative Care;2024